Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

41 Press Releases
DateTitleCompany
09 Apr 14 Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
24 Feb 14 Elanco Announces Agreement to Acquire Lohmann Animal Health ELI LILLY AND COMPANY - MARK TAYLOR,
Published by
PR Newswire
08 Jul 13 Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
25 Jun 13 Trajenta® (linagliptin): New data on safety and efficacy in Type 2 Diabetes patients with moderate to severe renal impairment Boehringer Ingelheim and Eli Lilly and Company,
Published by
Ogilvy HealthPR London
25 Jun 13 New efficacy and safety data presented for Trajenta® (linagliptin) in Asians with Type 2 Diabetes Boehringer Ingelheim and Eli Lilly and Company,
Published by
Ogilvy HealthPR London
31 May 13 New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
20 May 13 From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
13 May 13 Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma Eli Lilly and Company
06 Mar 13 Lilly Sets Date for 2013 Diabetes Pipeline Update to the Media and Investment Community Eli Lilly and Company
08 Jan 13 Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin Boehringer Ingelheim and Eli Lilly and Company,
Published by
Boehringer Ingelheim
24 Oct 12 New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Eli Lilly and Company
02 Oct 12 Pooled analysis in adults with type 2 diabetes Eli Lilly and Company
30 Aug 12 Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results Eli Lilly and Company
17 Nov 11 Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
31 Oct 11 Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership Eli Lilly and Company Lilly,
Published by
Eli Lilly and Company
21 Sep 11 Trajenta(linagliptin) launches in the UK for adults with type 2 diabetes mellitus Boehringer Ingelheim and Eli Lilly and Company,
Published by
PharmiWeb.com
20 Sep 11 Lilly Steps Up Efforts to Improve Diversity in Clinical Trials ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
28 Jun 11 Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
16 May 11 Lilly Provides Statement in Response to Amylin Lawsuit ELI LILLY AND COMPANY - MARK TAYLOR,
Published by
PR Newswire
15 Apr 11 American College of Endocrinology (ACE) and Lilly Diabetes Offer Free Checklist to Help People With Diabetes Prepare Before Disaster Strikes Eli Lilly and Company,
Published by
PharmiWeb.com
09 Mar 11 Lilly CEO Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation ELI LILLY AND COMPANY - COLLEEN PARKER,
Published by
PR Newswire
15 Feb 11 Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines ELI LILLY AND COMPANY - CHERYL CLIFFORD,
Published by
PR Newswire
17 Aug 10 Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials Eli Lilly and Company,
Published by
PR Newswire
08 Mar 10 Lilly to Acquire European Rights to Pfizer Animal Health Assets Eli Lilly and Company,
Published by
PR Newswire
25 Feb 10 Exenatide Once Weekly New Drug Application Review Extended by FDA Due to Weather-Related Closure Alkermes Inc. and Amylin Pharmaceuticals Inc. and Eli Lilly and Company,
Published by
Business Wire
16 Nov 09 Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor Eli Lilly and Company,
Published by
PR Newswire
25 Aug 09 Grammy(R)-Nominated R&B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African-Americans to be Victorious in the Face of Diabetes Eli Lilly and Company,
Published by
American Diabetes Association
06 Aug 09 Lilly Broadens Income Eligibility for Patient Assistance Programs Eli Lilly and Company,
Published by
Pharmiweb.com
06 Aug 09 Effient(TM) is Now Available in Pharmacies Daiichi Sankyo, Eli Lilly and Company,
Published by
Pharmiweb.com
03 Aug 09 Lilly Announces Continued Commitment to Transparency with Faculty Registry Eli Lilly and Company,
Published by
Pharmiweb.com
Advertising